Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas

Journal of Physiology

Volumn 591, Issue 9, 2013, Pages 2275-2285

  Peiró, Concepción ^a   Vallejo, Susana ^a,b   Gembardt, Florian ^c,d   Palacios, Erika ^a   Novella, Susana ^e,f   Azcutia, Verónica ^a   Rodríguez Mañas, Leocadio ^b   Hermenegildo, Carlos ^e,f   Sánchez Ferrer, Carlos F ^a   Walther, Thomas ^g,h  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c Excellencecluster Cardio Pulmonary System   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BRADYKININ; DEXTRO PROANGIOTENSIN[1-7]; MAS RECEPTOR; MEMBRANE RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MESENTERY BLOOD VESSEL; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; WILD TYPE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BRADYKININ; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVESSELS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; VASODILATION; VASODILATOR AGENTS;

EID: 84876969452     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.251413     Document Type: Article

References (32)

1. Ambuhl P, Felix D & Khosla MC (1994). [7-D-ALA]-angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus. Brain Res Bull 35, 289-291.
2. Benter IF, Diz DI & Ferrario CM (1993). Cardiovascular actions of angiotensin(1-7). Peptides 14, 679-684.
3. 11 by MAS. J Biol Chem 281, 16757-16767.
4. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE & Acton S (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87, E1-E9.
5. Ellefson DD, diZerega GS, Espinoza T, Roda N, Maldonado S & Rodgers KE (2004). Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 53, 15-24.
6. Esteban V, Heringer-Walther S, Sterner-Kock A, de Bruin R, van den Engel S, Wang Y, Mezzano S, Egido J, Schultheiss HP, Ruiz-Ortega M & Walther T (2009). Angiotensin-(1-7) and the G protein-coupled receptor Mas are key players in renal inflammation. PLoS One 4, e5406.
7. Freeman EJ, Chisolm GM, Ferrario CM & Tallant EA (1996). Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 28, 104-108.
8. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, Siems WE & Walther T (2005a). Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26, 1270-1277.
9. Gembardt F, van Veghel R, Coffman TM, Schultheiss HP, Danser AHJ & Walther T (2012). Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors. Hypertens Res 35, 547-551.
10. Gembardt F, Wieland T, Zhang J, Heiss A & Walther T (2005b). The G protein-coupled receptor Mas encoded by the Mas proto-oncogene shows mitogenic properties through a constitutive activation of rho. Naunyn Schmiedbergs Arch Pharmacol 370, R19.
11. 3H]norepinephrine from rat atria. Hypertension 24, 457-460.
12. Gironacci MM, Valera MS, Yujnovsky I & Peña C (2004). Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats. Hypertension 44, 783-787.
13. Handa RK, Ferrario CM & Strandhoy JW (1996). Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol Renal Physiol 270, F141-F147.
14. Heitsch H, Brovkovych S, Malinski T & Wiemer G (2001). Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 37, 72-76.
15. Lemos VS, Silva DMR, Walther T, Alenina N, Bader M & Santos RAS (2005). The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice. J Cardiovasc Pharmacol 46, 274-279.
16. Machado RDP, Ferreira MAND, Belo AV, Santos RAS & Andrade SP (2002). Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. Regul Pept 107, 105-113.
17. Neves LAA, Averill DB, Ferrario CM, Chappell MC, Aschner JL, Walkup MP & Brosnihan KB (2003). Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries. Peptides 24, 455-462.
18. Peiró C, Vallejo S, Gembardt F, Azcutia V, Heringer-Walther S, Rodríguez-Mañas L, Schultheiss HP, Sánchez-Ferrer CF & Walther T (2007). Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J Hypertens 25, 2421-2425.
19. Rodgers K, Xiong S & DiZerega GS (2003). Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother Pharmacol 51, 97-106.
20. Santos RA, Campagnole-Santos MJ, Baracho NC, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues AR, Gropen Júnior C, Carvalho WS, Simoes e Silva AC & Khosla MC (1994). Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 35, 293-298.
21. Santos RA, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SVB, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R & Walther T (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100, 8258-8263.
22. Silva DMR, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RAS & Lemos VS (2007). Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28, 702-707.
23. Stegbauer J, Potthoff SA, Quack I, Mergia E, Clasen T, Friedrich S, Vonend O, Woznowski M, Königshausen E, Sellin L & Rump LC (2011). Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice. Br J Pharmacol 163, 974-983.
24. Strawn WB, Ferrario CM & Tallant EA (1999). Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33, 207-211.
25. Takeda H, Katagata Y, Hozumi Y & Kondo S (2004). Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol 165, 1653-1662.
26. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G & Turner AJ (2000). A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275, 33238-33243.
27. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stoll M, Stroth U & Zhu YZ (1996). Angiotensin receptors. J Hypertens Suppl 14, S95-S103.
28. Vallejo S, Angulo J, Peiró C, Nevado J, Sánchez-Ferrer A, Petidier R, Sánchez-Ferrer CF & Rodríguez-Mañas L (2000). Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia 43, 83-90.
29. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A & Tummino P (2002). Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277, 14838-14843.
30. Weir MR & Dzau VJ (1999). The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 12, 205S-213S.
31. Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW & Wright JW (2005). Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Res 1060, 108-117.
32. Zhu Z, Zhong J, Zhu S, Liu D, Van Der Giet M & Tepel M (2002). Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction. J Cardiovasc Pharmacol 40, 693-700.